Medical Ikkou Group Co., Ltd. (JP:3353)
:3353
Top Page
Medical Ikkou Group Co., Ltd.
(3353)
Select Model
Select Model
Rating:65Neutral
Price Target:
¥3,112.00
▲(6.21% Upside)
Action:ReiteratedDate:04/08/26
The score is supported most by attractive valuation (low P/E and strong dividend yield). This is tempered by weaker financial quality—especially volatile and weak cash conversion—and only neutral-to-soft technical momentum.
Positive Factors
Improving Revenue Growth
Sustained top-line acceleration across recent annual periods signals improving market traction and demand for the company’s offerings. Durable revenue momentum supports capacity utilization, strategic reinvestment and greater scale economics over the next several months, reducing execution risk.
Negative Factors
Weak Cash Conversion
Very low operating cash conversion versus reported earnings indicates earnings quality issues and suggests reliance on non-cash items or working-capital swings. This erodes the reliability of reported profits to fund dividends and investments, raising structural financing risk.
Read all positive and negative factors
Positive Factors
Negative Factors
Improving Revenue Growth
Sustained top-line acceleration across recent annual periods signals improving market traction and demand for the company’s offerings. Durable revenue momentum supports capacity utilization, strategic reinvestment and greater scale economics over the next several months, reducing execution risk.
Read all positive factors
Medical Ikkou Group Co., Ltd. (3353) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥10.01B
Dividend Yield3.51%
Average Volume (3M)5.09K
Price to Earnings (P/E)9.0
Beta (1Y)0.39
Revenue Growth16.73%
EPS Growth-16.51%
CountryJP
Employees1,431
SectorIndustrials
Sector Strength72
IndustryConglomerates
Share Statistics
EPS (TTM)87.16
Shares Outstanding3,770,000
10 Day Avg. Volume10,430
30 Day Avg. Volume5,086
Financial Highlights & Ratios
PEG Ratio0.73
Price to Book (P/B)0.73
Price to Sales (P/S)0.21
P/FCF Ratio52.19
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Medical Ikkou Group Co., Ltd. Business Overview & Revenue Model
Company Description
Medical Ikkou Group Co.,Ltd. operates dispensing pharmacies in Japan. The company is also involved in the operation of nursing homes, outpatient nursing care facilities, and home-visit nursing care facilities; wholesale of generic drugs; and renta...
How the Company Makes Money
Detailed, publicly verifiable information describing Medical Ikkou Group Co., Ltd. (3353)'s revenue model (e.g., primary revenue streams, segment-level drivers, and material partnerships) is null....
Medical Ikkou Group Co., Ltd. Financial Statement Overview
Summary
Income Statement
74
Positive
Balance Sheet
70
Positive
Cash Flow
46
Neutral
| Breakdown | TTM | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 52.66B | 54.98B | 48.39B | 39.90B | 33.90B | 33.60B |
| Gross Profit | 5.98B | 6.36B | 5.61B | 4.38B | 2.97B | 3.37B |
| EBITDA | 2.42B | 2.63B | 2.46B | 2.34B | 1.78B | 2.15B |
| Net Income | 1.09B | 1.28B | 1.13B | 1.04B | 759.60M | 852.33M |
Balance Sheet | ||||||
| Total Assets | 37.91B | 37.52B | 34.23B | 31.66B | 27.51B | 29.09B |
| Cash, Cash Equivalents and Short-Term Investments | 8.60B | 6.12B | 6.77B | 7.70B | 6.44B | 7.99B |
| Total Debt | 11.43B | 10.36B | 10.04B | 9.60B | 9.15B | 11.35B |
| Total Liabilities | 22.64B | 21.24B | 19.52B | 17.82B | 14.90B | 17.17B |
| Stockholders Equity | 14.64B | 15.63B | 14.10B | 13.24B | 12.05B | 11.38B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 219.98M | 201.34M | 3.97B | 995.40M | 812.29M |
| Operating Cash Flow | 0.00 | 1.21B | 1.20B | 4.28B | 1.31B | 1.14B |
| Investing Cash Flow | 0.00 | -1.81B | -1.13B | -3.22B | -477.52M | 539.48M |
| Financing Cash Flow | 0.00 | -283.62M | -1.03B | 277.76M | -2.37B | -690.26M |
Medical Ikkou Group Co., Ltd. Technical Analysis
Positive
2930.00
Price Trends
2936.79
Negative
2830.78
Positive
2851.21
Positive
Market Momentum
-14.75
Negative
49.86
Neutral
71.06
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3353, the sentiment is Positive. The current price of 2930 is above the 20-day moving average (MA) of 2878.95, below the 50-day MA of 2936.79, and above the 200-day MA of 2851.21, indicating a neutral trend. The MACD of -14.75 indicates Negative momentum. The RSI at 49.86 is Neutral, neither overbought nor oversold. The STOCH value of 71.06 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3353.
Medical Ikkou Group Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥6.54B | 1.85 | ― | 3.35% | 7.25% | -11.62% | |
69 Neutral | ¥17.67B | 4.12 | ― | 2.71% | 2.13% | 135.50% | |
65 Neutral | ¥10.01B | 9.00 | ― | 3.51% | 16.73% | -16.51% | |
64 Neutral | ¥11.41B | 1.66 | ― | 0.72% | ― | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | ¥31.03B | 18.38 | ― | 3.90% | 5.66% | -10.44% | |
58 Neutral | ¥13.73B | 5.37 | ― | 3.88% | 15.50% | ― |
* Industrials Sector Average
JP:3353
Medical Ikkou Group Co., Ltd.
2,895.00
749.01
34.90%
JP:2462
LIKE, Inc.
1,617.00
274.88
20.48%
JP:6838
Tamagawa Holdings Co., Ltd.
1,345.00
737.42
121.37%
JP:7119
halmek holdings Co.,Ltd.
1,600.00
560.53
53.92%
JP:7509
I. A Group Corporation
4,415.00
1,416.67
47.25%
JP:9248
People, Dreams & Technologies Group Co., Ltd.
1,526.00
71.56
4.92%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.